Yun JH. Hepatocyte growth factor prevents pericyte loss in diabetic retinopathy. Microvasc Res. 2021;133:104103.
Granstam E, Aurell S, Sjövall K, Paul A. Switching anti-VEGF agent for wet AMD: evaluation of impact on visual acuity, treatment frequency and retinal morphology in a real-world clinical setting. Graefes Arch Clin Exp Ophthalmol. 2021;259:2085–93.
CAS PubMed PubMed Central Google Scholar
Cécile D. Epidemiology of age-related macular degeneration. La Rev du praticien. 2017;67:88–91.
Mettu PS, Allingham MJ, Cousins SW. Incomplete response to anti-VEGF therapy in neovascular AMD: Exploring disease mechanisms and therapeutic opportunities. Prog Retin Eye Res. 2020;82:100906.
Sun X, Yang S, Zhao J. Resistance to anti-VEGF therapy in neovascular age-related macular degeneration: a comprehensive review. Drug Des Dev Ther. 2016;10:1857–67.
Ehlken C, Jungmann S, Bhringer D, Agostini HT, Pielen A. Switch of anti-VEGF is an option for nonresponders in the treatment of AMD. Eye. 2014;28:538–45.
CAS PubMed PubMed Central Google Scholar
Tian Y, Zhang F, Qiu Y, Wang S, Li F, Zhao J, et al. Reduction of choroidal neovascularization via cleavable VEGF antibodies conjugated to exosomes derived from regulatory T cells. Nat Biomed Eng. 2021;5:968–82.
Wallsh JO, Gallemore RP. Anti-VEGF-resistant retinal diseases: a review of the latest treatment options. Cells. 2021;10:1049.
CAS PubMed PubMed Central Google Scholar
Pb A, Nam A, Tacma B, Wudunn AD, Lbc A. The acute and chronic effects of intravitreal anti-vascular endothelial growth factor injections on intraocular pressure: a review. Surv Ophthalmol. 2018;63:281–95.
Baek SU, Park IW, Suh W. Long-term intraocular pressure changes after intravitreal injection of bevacizumab. Cutan Ocul Toxicol. 2016;35:310–4.
Rayess N, Rahimy E, Storey P, Shah CP, Wolfe JD, Chen E, et al. Postinjection endophthalmitis rates and characteristics following intravitreal bevacizumab, ranibizumab, and aflibercept. Am J Ophthalmol. 2016;165:88–93.
Ren C, Hui S, Jiang J, Liu Q, Du Y, He M, et al. The effect of CM082, an oral tyrosine kinase inhibitor, on experimental choroidal neovascularization in rats. J Ophthalmol. 2017;2017:6145651.
PubMed PubMed Central Google Scholar
Kechagia JZ, Ivaska J, Roca-Cusachs P. Integrins as biomechanical sensors of the microenvironment. Nat Rev Mol Cell Biol. 2019;20:1–17.
Hu TT, Vanhove M, Porcu M, Van Hove I, Van Bergen T, Jonckx B, et al. The potent small molecule integrin antagonist THR-687 is a promising next-generation therapy for retinal vascular disorders. Exp Eye Res. 2019;180:43–52.
Umeda N, Shu K, Akiyama H, Zahn G, Campochiaro PA. Suppression and regression of choroidal neovascularization by systemic administration of an α5β1 integrin antagonist. Mol Pharmacol. 2006;69:1820–8.
Ramakrishnan V, Bhaskar V, Law DA, Wong MH, DuBridge RB, Breinberg D, et al. Preclinical evaluation of an anti-alpha5beta1 integrin antibody as a novel anti-angiogenic agent. J Exp Ther Oncol. 2006;5:273–86.
Nebbioso M, Lambiase A, Cerini A, Limoli PG, La Cava M, Greco A. Therapeutic approaches with intravitreal injections in geographic atrophy secondary to age-related macular degeneration: current drugs and potential molecules. Int J Mol Sci. 2019;20:1693.
CAS PubMed Central Google Scholar
Askew BC, Furuya T, Edwards DS. Pharmacodynamics and pharmacokinetics of SF0166, a topically administered αvβ3 integrin antagonist, for the treatment of retinal diseases. J Pharmacol Exp Ther. 2018;366:jpet.118.248427.
Cao H, Xia W, Shen Q, Hua L, Jian Y, Li A, et al. Role of JWA in acute promyelocytic leukemia cell differentiation and apoptosis triggered by retinoic acid, 12-tetradecanoylphorbol-13-acetate and arsenic trioxide. Chin Sci Bull. 2002;47:834–8.
Chen Y, Huang Y, Huang Y, Xia X, Zhang J, Zhou Y, et al. JWA suppresses tumor angiogenesis via Sp1-activated matrix metalloproteinase-2 and its prognostic significance in human gastric cancer. Carcinogenesis. 2014;35:442–51.
Cui J, Shu C, Xu J, Chen D, Zhou J. JP1 suppresses proliferation and metastasis of melanoma through MEK1/2 mediated NEDD4L-SP1-Integrin αvβ3 signaling. Theranostics. 2020;10:8036–50.
CAS PubMed PubMed Central Google Scholar
Lambert V, Lecomte J, Hansen S, Blacher S, Gonzalez M, Struman I, et al. Laser-induced choroidal neovascularization model to study age-related macular degeneration in mice. Nat Protoc. 2013;8:2197–211.
Li L, Zhu M, Wu W, Qin B, Ding D. Brivanib, a multitargeted small-molecule tyrosine kinase inhibitor, suppresses laser-induced CNV in a mouse model of neovascular AMD. J Cell Physiol. 2020;235:1259–73.
Lai K, Gong Y, Zhao W, Li L, Jin C. Triptolide attenuates laser-induced choroidal neovascularization via M2 macrophage in a mouse model. Biomed Pharmacother. 2020;129:110312.
Bergen TV, Hu TT, Etienne I, Reyns GE, Moons L, Feyen J Neutralization of placental growth factor as a novel treatment option in diabetic retinopathy. Exp Eye Res. 2017:S0014483517304505.
Naderi A, Zahed R, Aghajanpour L, Amoli FA, Lashay A. Long term features of diabetic retinopathy in streptozotocin-induced diabetic Wistar rats. Exp Eye Res. 2019;184:213–20.
Indaram M, Ma W, Zhao L, Fariss RN, Rodriguez IR, Wong WT. 7-Ketocholesterol increases retinal microglial migration, activation, and angiogenicity: a potential pathogenic mechanism underlying age-related macular degeneration. Sci Rep. 2015;5:9144.
PubMed PubMed Central Google Scholar
Karlstetter M, Scholz R, Rutar M, Wong WT, Provis JM, Langmann T. Retinal microglia: just bystander or target for therapy? Prog Retin Eye Res. 2015;45:30–57.
Kinuthia UM, Wolf A, Langmann T. Microglia and inflammatory responses in diabetic retinopathy. Front Immunol. 2020;11:564077.
CAS PubMed PubMed Central Google Scholar
Yang Y, Liu F, Tang M, Yuan M, Hu A, Zhan Z, et al. Macrophage polarization in experimental and clinical choroidal neovascularization. Sci Rep. 2016;6:30933.
CAS PubMed PubMed Central Google Scholar
Bretz CA, Divoky V, Prchal J, Kunz E, Simmons AB, Wang H, et al. Erythropoietin signaling increases choroidal macrophages and cytokine expression, and exacerbates choroidal neovascularization. Sci Rep. 2018;8:2161.
PubMed PubMed Central Google Scholar
Yeo NJY, Chan EJJ, Cheung C. Choroidal neovascularization: mechanisms of endothelial dysfunction. Front Pharmacol. 2019;10:1363.
CAS PubMed PubMed Central Google Scholar
Kim SY, Kambhampati SP, Bhutto IA, Mcleod DS, Kannan RM. Evolution of oxidative stress, inflammation and neovascularization in the choroid and retina in a subretinal lipid induced age-related macular degeneration model. Exp Eye Res. 2020;203:108391.
Zhao X, Wang R, Xiong J, Yan D, Li A, Wang S, et al. JWA antagonizes paraquat-induced neurotoxicity via activation of Nrf2. Toxicol Lett. 2017;277:32–40.
Datta S, Cano M, Ebrahimi K, Wang L, Handa JT. The impact of oxidative stress and inflammation on RPE degeneration in non-neovascular AMD. Prog Retin Eye Res. 2017;60:201–18.
CAS PubMed PubMed Central Google Scholar
Lier J, Streit WJ, Bechmann I. Beyond activation: characterizing microglial functional phenotypes. Cells. 2021;10:2236.
CAS PubMed PubMed Central Google Scholar
Kim YJ, Park SY, Koh YJ, Lee JH. Anti-neuroinflammatory effects and mechanism of action of Fructus ligustri lucidi extract in BV2 microglia. Plants. 2021;10:688.
CAS PubMed PubMed Central Google Scholar
Lu J, Tang Y, Farshidpour M, Cheng Y, Zhang G, Jafarnejad SM, et al. JWA inhibits melanoma angiogenesis by suppressing ILK signaling and is an independent prognostic biomarker for melanoma. Carcinogenesis. 2013;34:2778–88.
Chen JJ, Ren YL, Shu CJ, Zhang Y, Chen MJ, Xu J, et al. JP3, an antiangiogenic peptide, inhibits growth and metastasis of gastric cancer through TRIM25/SP1/MMP2 axis. J Exp Clin Cancer Res. 2020;39:118.
PubMed PubMed Central Google Scholar
Capitão M, Soares R. Angiogenesis and inflammation crosstalk in diabetic retinopathy. J Cell Biochem. 2016;117:2443–53.
Hamdan F, Bigdeli Z, Asghari SM, Sadremomtaz A, Balalaie S. Synthesis of modified RGD-based peptides and their in vitro activity. ChemMedChem. 2019;14:282–8.
Semeraro F, Cancarini A, Dell’Omo R, Rezzola S, Romano MR, Costagliola C. Diabetic retinopathy: vascular and inflammatory disease. J Diabetes Res. 2015;2015:1–16.
Arroba AI, Valverde Á. Modulation of microglia in the retina: new insights into diabetic retinopathy. Acta Diabetol. 2017;54:527.
Wang M, Wang X, Zhao L, Ma W, Rodriguez IR, Fariss RN, et al. Macroglia-microglia interactions via TSPO signaling regulates microglial activation in the mouse retina. J Neurosci. 2014;34:3793–806.
CAS PubMed PubMed Central Google Scholar
Alves CH, Fernandes R, Santiago AR, Ambrósio AF. Microglia contribution to the regulation of the retinal and choroidal vasculature in age-related macular degeneration. Cells. 2020;9:1217.
CAS PubMed Central Google Scholar
Zhang T, Ouyang H, Mei X, Lu B, Yu Z, Chen K, et al. Erianin alleviates diabetic retinopathy by reducing retinal inflammation initiated by microglial cells via inhibiting hyperglycemia-mediated ERK1/2-NF-κB signaling pathway. FASEB J. 2019;33:11776
留言 (0)